GE HealthCare (GEHC) Tops Q2 EPS by 9c, Beats on Revenue; Reaffirms Guidance

GE HealthCare (NASDAQ: GEHC) reported Q2 EPS of $1.13, $0.09 better than the analyst estimate of $1.04. Revenue for the quarter came in at $5.3 billion versus the consensus estimate of $5.26 billion.

The company reaffirmed its full-year 2026 guidance.

For earnings history and earnings-related data on GE HealthCare (GEHC) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• SmartKem (SMTK) files for 15.13M share offering by selling stockholders
• InMed Pharmaceuticals gets Nasdaq equity deficiency notice